The Fe3O4 nanoparticles provided sufficient Fe2+ for ferroptosis in drug-resistant GBM cells, and siRNA-mediated PD-L1 downregulation promoted DC maturation and T-cell activation (70). This evidence concerns the gene CD274 and glioblastoma.